Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
Christopher J. Schwartz(University of California, San Francisco), Gregor Krings(Cleveland Clinic), Amie Blanco(University of California, San Francisco), Rita A. Mukhtar(University of California, San Francisco), Nikka Khorsandi(University of California, San Francisco), Yunn‐Yi Chen(University of Vermont)
Cited by 13
Related Papers
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations
|Human Mutation|2018|319
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast
|Archives of Pathology & Laboratory Medicine|2009|304